Gilles Rouault

Suggest Changes
Learn More
BACKGROUND Gender differences in presentation, management and outcome in patients with ST-segment elevation myocardial infarction (STEMI) have been reported. AIM To determine whether female gender(More)
BACKGROUND Antiplatelet therapies, including prasugrel, are a cornerstone in the treatment of ST-segment elevation myocardial infarction (STEMI), but are associated with a bleeding risk. This risk(More)
Aims To derive and validate a readily useable risk score to identify patients at high-risk of in-hospital ST-segment elevation myocardial infarction (STEMI)-related cardiogenic shock (CS). Methods(More)
BACKGROUND Despite numerous studies in recent years, the best anticoagulant option for primary percutaneous coronary intervention (PCI) remains a matter of debate. AIMS To compare in-hospital(More)
BACKGROUND Literature suggests that radial access is associated with higher radiation doses than femoral access. AIMS To compare patient radiation exposure during coronary angiography (CA) and(More)
TCT-128 A systematic review and meta-analysis of extracorporeal life support during cardiac arrest and cardiogenic shock Dagmar Ouweneel, Jasper Schotborgh, Jaqueline Limpens, Krischan Sjauw,(More)
Previous studies investigating prehospital use of glycoprotein IIb/IIIa inhibitors (GPIs) in patients with ST-segment elevation myocardial infarction reached conflicting conclusions. The benefit of(More)
BACKGROUND Acute heart failure (AHF) complicating ST-segment elevation myocardial infarction (STEMI) is recognized as an ominous complication. Previous studies mostly reported outcomes of(More)
BACKGROUND Recent studies demonstrated the superiority of complete revascularization (CR) in patients treated by primary percutaneous coronary intervention (pPCI) in ST-elevation myocardial(More)